Cargando…
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90
[Image: see text] Histone deacetylase 6 (HDAC6) and heat shock protein 90 (Hsp90) are widely investigated anticancer drug targets. Importantly, several lines of evidence indicate that their regulation and activity are intimately linked, and that their combined inhibition may lead to impressive thera...
Autores principales: | Pinzi, Luca, Benedetti, Rosaria, Altucci, Lucia, Rastelli, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254527/ https://www.ncbi.nlm.nih.gov/pubmed/32478236 http://dx.doi.org/10.1021/acsomega.0c00559 |
Ejemplares similares
-
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
por: Linciano, Pasquale, et al.
Publicado: (2021) -
Synergism of Heat Shock Protein 90 and Histone Deacetylase Inhibitors in Synovial Sarcoma
por: Nguyen, Anne, et al.
Publicado: (2009) -
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
por: Pinzi, Luca, et al.
Publicado: (2021) -
Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
por: Liu, Ping, et al.
Publicado: (2021) -
Heat Shock Protein 90 Regulates the Activity of Histone Deacetylase Sir2 in Plasmodium falciparum
por: Tabassum, Wahida, et al.
Publicado: (2022)